3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
66
Cisplatin
54
Radiotherapy, Intensity-Modulated
28
Carboplatin
27
Nivolumab
26
Paclitaxel
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
19
Cetuximab
16
Specimen Handling
15
Docetaxel
15
Radiation
14
Gemcitabine
13
Fluorouracil
12
Biopsy
12
durvalumab
11
Platinum
11
Taxes
10
Surveys and Questionnaires
10
Drug Therapy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Capecitabine
9
trametinib
8
tislelizumab
6
lenvatinib
6
dabrafenib
6
cemiplimab
6
atezolizumab
6
Radiosurgery
6
Ipilimumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Radionuclide Imaging
×
Head & Neck
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled